Your browser doesn't support javascript.
loading
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Walls, Gerard M; Oughton, Jamie B; Chalmers, Anthony J; Brown, Sarah; Collinson, Fiona; Forster, Martin D; Franks, Kevin N; Gilbert, Alexandra; Hanna, Gerard G; Hannaway, Nicola; Harrow, Stephen; Haswell, Tom; Hiley, Crispin T; Hinsley, Samantha; Krebs, Matthew; Murden, Geraldine; Phillip, Rachel; Ryan, Anderson J; Salem, Ahmed; Sebag-Montefoire, David; Shaw, Paul; Twelves, Chris J; Walker, Katrina; Young, Robin J; Faivre-Finn, Corinne; Greystoke, Alastair.
Afiliación
  • Walls GM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland, UK.
  • Oughton JB; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Chalmers AJ; Institute of Cancer Sciences, University of Glasgow, Scotland, UK.
  • Brown S; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Collinson F; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Forster MD; Department of Oncology, UCL Cancer Institute, England, UK.
  • Franks KN; St James' Institute of Oncology, University of Leeds, England, UK.
  • Gilbert A; St James' Institute of Oncology, University of Leeds, England, UK.
  • Hanna GG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia.
  • Hannaway N; Newcastle University, Newcastle upon Tyne, England, UK.
  • Harrow S; The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.
  • Haswell T; Patient and Public Involvement Advocacy, UK.
  • Hiley CT; Department of Oncology, UCL Cancer Institute, England, UK.
  • Hinsley S; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Krebs M; Institute of Cancer Sciences, University of Glasgow, Scotland, UK.
  • Murden G; Faculty of Biology, Medicine and Health, University of Manchester, England, UK.
  • Phillip R; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Ryan AJ; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Salem A; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, England, UK.
  • Sebag-Montefoire D; The Christie NHS Foundation Trust/University of Manchester, Manchester, England, UK.
  • Shaw P; St James' Institute of Oncology, University of Leeds, England, UK.
  • Twelves CJ; Velindre University NHS Trust, Cardiff, Wales, UK.
  • Walker K; St James' Institute of Oncology, University of Leeds, England, UK.
  • Young RJ; Leeds Institute of Clinical Trials Research, University of Leeds, England, UK.
  • Faivre-Finn C; Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, England, UK.
  • Greystoke A; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, England, UK.
Clin Transl Radiat Oncol ; 25: 61-66, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33072895
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Clin Transl Radiat Oncol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Clin Transl Radiat Oncol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda